Curoverse Raises $1.5M to Commercialize PGP's Software | GenomeWeb

NEW YORK (GenomeWeb News) – Curoverse has raised $1.5 million in seed money that it will use to develop commercial software products based on Arvados, an open-source computational storage platform that was developed to support Harvard's Personal Genome Project.

The funds raised in the round include investments from Hatteras Venture Partners, Point Judith Ventures, Common Angels, MassVentures, and Boston Global Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.